The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
methylparaoxon results in decreased activity of ACHE protein 4-(aminocarbonyl)-1-(3-(4-((E)-(hydroxyimino)methyl)pyridinium-1-yl)propyl)pyridinium dibromide inhibits the reaction [methylparaoxon results in decreased activity of ACHE protein]; asoxime chloride inhibits the reaction [methylparaoxon results in decreased activity of ACHE protein]; K-48 compound inhibits the reaction [methylparaoxon results in decreased activity of ACHE protein]; N,N'-monomethylenebis(pyridiniumaldoxime) inhibits the reaction [methylparaoxon results in decreased activity of ACHE protein]; Obidoxime Chloride inhibits the reaction [methylparaoxon results in decreased activity of ACHE protein]; pralidoxime inhibits the reaction [methylparaoxon results in decreased activity of ACHE protein]
AKR1C1 protein affects the susceptibility to [Benzo(a)pyrene co-treated with methylparaoxon] methylparaoxon results in increased expression of AKR1C1 mRNA
AKR1C2 protein affects the susceptibility to [Benzo(a)pyrene co-treated with methylparaoxon] methylparaoxon results in increased expression of AKR1C2 mRNA
methylparaoxon results in increased expression of CYP1A1 mRNA methylparaoxon inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A1 mRNA]
[Calcium results in increased activity of PON1 protein] which results in decreased susceptibility to methylparaoxon; [Egtazic Acid results in decreased activity of PON1 protein] which results in increased susceptibility to methylparaoxon